This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Kite Pharma, Inc., Cell Design Labs, Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Contributions of Sarah Wyman
Introduction
Sarah Wyman is a prominent inventor based in Oakland, CA. She has made significant contributions to the field of biotechnology, particularly in the development of engineered receptors and chimeric transmembrane proteins. With a total of 4 patents, her work has the potential to impact cancer treatment and cytokine signaling.
Latest Patents
Wyman's latest patents include "TGF-beta receptors and methods of use" and "Chimeric transmembrane proteins and uses thereof." The first patent provides engineered receptors involved in cytokine signaling, as well as methods for modulating TGF-β signaling and treating cancer using chimeric antigen receptors. The second patent focuses on chimeric transmembrane proteins, including nucleic acids encoding these proteins and methods for making and using mammalian cells containing them.
Career Highlights
Sarah Wyman is currently employed at Kite Pharma, Inc., where she continues to advance her research in the field of biotechnology. Her innovative work has garnered attention and respect within the scientific community.
Collaborations
Wyman collaborates with notable colleagues such as Peter Emtage and Gabrielle Romain, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Sarah Wyman's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also holds promise for future medical applications.